Delivery Order SPE2DB25D3402-SPE2DB25FUGJU
- Not listed
- The Defense Logistics Agency awarded a $7,983.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Gemtesa 75 mg, with an ultimate completion date of July 24, 2025. This non-set-aside competitive award was issued to AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, where the pharmaceutical products will be delivered. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements,...
- The Defense Logistics Agency awarded a $57,659.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90-count bottles of Gemtesa 75 mg tablets, with an ultimate completion date of July 25, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's broader supply relationship with the federal government. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,279.87 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (30-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and healthcare systems. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count units) valued at $7,179.96. This firm fixed-price, non-set-aside contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award represents a single fulfillment action under a larger contracting vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $9,503.28 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed price, competitively awarded delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $22,337.44 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units). This firm fixed-price contract, issued on July 30, 2025, represents a non-competitive, non-set-aside award with an ultimate completion date of July 31, 2025. The pharmaceutical products will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $11,378.69 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and...
- The Defense Logistics Agency awarded a delivery order valued at $9,322.87 to AmerisourceBergen Drug Corp for 90-count tablets of Gemtesa 75 mg on July 28, 2025, with completion expected by July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $10,584.22 delivery order to AmerisourceBergen Drug Corp for 90-count bottles of Gemtesa 75 mg tablets, with performance in Conshohocken, Pennsylvania and a completion deadline of July 31, 2025. This competitively awarded, firm fixed price contract contains no set-aside designation and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,068.92 by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Gemtesa 75 mg tablets (30 count). The contract is a firm fixed price delivery order with an ultimate completion date of July 29, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and represents a competitive award to the prime contractor. This...
- SPE2DB25D3402Indefinite Delivery Contract
- SPE2DB25D3402-SPE2DB25FUGJUDelivery Order
The Defense Logistics Agency awarded a $3,493.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Gemtesa 75 mg, with an ultimate completion date of August 4, 2025. This non-competitive delivery order, issued on August 1, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999,999,999.00 indefinite delivery contract (SPE2DX) with DLA Troop Support Medical running through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The Gemtesa delivery represents one of numerous orders fulfilled under this framework, which covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 8/1/25 |